A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Episode 50: Moonshots and healthcare. Why a radical approach is needed to save healthcare. When it comes to innovation, look no further than the...
Deena Shakir chats with Jonathan Slotkin, Chief Medical Officer at Contigo, and Kaycee Kalpin, Chief Marketing Officer at Premier Inc., to discuss her career journey...
PAS continues to spearhead research in understanding outcomes of COVID-19 and its impact on pregnant women, increased risk of myocarditis and healthcare resource utilization.
New challenges call for new thinking. Premier and its members, will continue to innovate in the sustainability space in the months and years to come.
There is an urgent need to understand the clinical and economic consequences associated with AKI in hospitalized patients with COVID-19 to better inform treatment decisions...
The SARS-Cov-2 delta variant has filled U.S. hospitals to capacity reinforcing the need for data to better understand disease severity and support evidence-based treatment decisions...
Premier Applied Sciences and Meitheal Pharmaceuticals collaborate to study anticoagulant use in COVID-19 patients.
Forbes | A new study conducted via the U.S. Premier Healthcare Database revealed nearly one in every four Covid-19 deaths may be attributed to hospital strain.
See how we're leveraging our rich data sets to uncover new oncology insights.
Financial Times | Premier's Roni Christopher weighs in on the FDA's approval of a Biogen treatment for patients with Alzheimer's disease.
Premier Applied Sciences to analyze study results and evaluation of the product aimed at improving outcomes and lowering costs for male urinary disorders.
Mike Alkire and Diana Brainard, SVP and Virology Therapeutic Area Head at Gilead, talk about launching a new therapy during COVID-19.